结节型边缘区淋巴瘤的遗传学分析及与其他小B细胞淋巴瘤的鉴别诊断
该研究对52例诊断为结节型边缘区淋巴瘤(NMZL)或需鉴别诊断的病例进行靶向二代测序和基因表达谱分析。经形态学和突变分析后,38例(73%)归类为NMZL,8例(15%)为t(14;18)阴性滤泡性淋巴瘤(FL),6例(12%)为表型不典型的慢性淋巴细胞白血病/小淋巴细胞淋巴瘤(CLL/SLL)。NMZL中最常见突变为KLF2(34%),其次为KMT2D(21%)和TBL1XR1(16%);NF-kB通路(13%)、NOTCH通路(16%)及染色质重塑和转录调控相关基因(55%)常受累。基因表达谱显示NMZL与t(14;18)阴性FL转录谱不同,后者上调生发中心及IL-4通路相关基因,NMZL上调记忆B细胞相关基因。结论认为NMZL虽具遗传异质性,但存在反复遗传学改变导致特定通路扰动,结合其他发现有助于鉴别NMZL与其他小B细胞淋巴瘤。
要点
- NMZL最常见突变为KLF2(34%),其次KMT2D(21%)和TBL1XR1(16%)。
- NF-kB通路(13%)、NOTCH通路(16%)及染色质重塑/转录调控基因(55%)常受累。
- 基因表达谱可区分NMZL与t(14;18)阴性FL,后者上调生发中心及IL-4通路基因。
核心结论
- NMZL虽具遗传异质性,但存在反复遗传学改变导致特定通路扰动,结合其他发现有助于鉴别诊断。
研究设计与样本
- 对52例诊断为NMZL或需鉴别诊断的病例进行靶向二代测序和基因表达谱分析。
主要发现
- 经形态学和突变分析后,38例(73%)归类为NMZL,8例(15%)为t(14;18)阴性FL,6例(12%)为表型不典型CLL/SLL。
- NMZL中最常见突变为KLF2(34%),其次为KMT2D(21%)和TBL1XR1(16%)。
- NF-kB通路(13%)、NOTCH通路(16%)及染色质重塑和转录调控相关基因(55%)常受累。
- 基因表达谱显示NMZL与t(14;18)阴性FL转录谱不同,后者上调生发中心及IL-4通路相关基因,NMZL上调记忆B细胞相关基因。
临床怎么用
- 分子分析(靶向测序和基因表达谱)可作为辅助手段,结合病理和遗传特征区分NMZL与其他小B细胞淋巴瘤。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Nodal marginal zone lymphoma (NMZL) is a rare indolent B-cell lymphoma without a disease-defining phenotype. The distinction from other small B-cell lymphomas is challenging, especially from t(14;18)-negative follicular lymphoma (FL). To find out whether molecular analysis could help in separating NMZL from other small B-cell lymphomas, we analyzed a cohort of 52 cases with the diagnosis or differential diagnosis of NMZL using targeted next generation sequencing and gene expression profiling (GEP). After morphological and mutational analysis, 38 (73%) cases were classified as NMZL, 8 (15%) cases as t(14;18)-negative FL and 6 (12%) cases as chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) with atypical phenotype. The most frequently mutated gene in NMZL was KLF2 (34%), followed by KMT2D (21%) and TBL1XR1 (16%). Overall, the NF-kB pathway (13%), the NOTCH pathway (16%) and genes involved in chromatin remodeling and transcriptional regulation (55%) were frequently affected. Confirming the classification based on pathological and genetic features, GEP revealed distinct transcriptional profiles for NMZL and t(14;18)-negative FL. While the latter group showed upregulation of genes associated with the germinal center and the IL-4 pathway, NMZL revealed upregulation of genes identified in memory B cells. In summary, despite showing genetic heterogeneity, NMZL is characterized by recurrent genetic alterations resulting in perturbations of specific pathways. These alterations, although not specific per se, render very characteristic genetic profiles, and when used in the context of other findings are a useful adjunct to distinguish NMZL from other small B-cell lymphomas.
引用
- Borgmann V, Gierer HS, Paigin S, et al. Nodal marginal zone lymphoma: genetic analysis and the differential diagnosis from other small B-cell lymphomas. Blood Adv. 2026. PMID: 42721462. doi:10.1182/bloodadvances.2026020849
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。